首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1609690

2025-2033 年日本分子診斷市場報告（依產品、技術（聚合酶鍊式反應、雜交、DNA 定序、微陣列、等溫核酸擴增技術等）、應用、最終用戶和地區）

Japan Molecular Diagnostics Market Report by Product, Technology (Polymerase Chain Reactions, Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology, and Others), Application, End User, and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 116 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年日本分子診斷市場IMARC Group達12億美元。包括癌症和心血管疾病在內的慢性疾病的盛行率不斷上升，老年人口需要獨特的醫療保健需求和更高的特定疾病傾向，以及下一代定序和即時 PCR 等先進技術的整合代表了一些推動市場的關鍵因素。

分子診斷是指用於分析基因組和蛋白質組中的生物標記的技術的集合。此類診斷使醫療專業人員能夠檢測和測量與特定健康狀況或疾病狀態相關的遺傳物質或蛋白質的存在。分子診斷的特點是精確度、準確性和速度，以及它們在醫療保健系統中的重要作用。這些診斷方法採用 PCR（聚合酶鍊式反應）、ISH（原位雜合技術）和 DNA 定序等技術來揭示特定的遺傳訊息。他們的工作機制涉及提取、擴增和分析遺傳物質，首先是分離 DNA 或 RNA，以擴增目標遺傳區域。然後透過各種方法檢查擴增的遺傳物質以識別突變或變化，使醫療保健提供者能夠就診斷和治療做出明智的決定。分子診斷的敏感性、特異性和同時處理多個樣本的能力等特性使其在提供及時和客製化的醫療治療方面具有優勢，從而為個人化醫療提供了一個有前景的系統。

日本分子診斷市場趨勢：

日本市場的主要驅動力是慢性病盛行率的不斷上升，包括癌症和心血管疾病，這需要早期和精確的檢測。與此一致的是，日本不斷成長的老年人口，需要獨特的醫療保健需求和更高的特定疾病傾向，也為市場提供了動力。此外，次世代定序和即時PCR等先進技術的整合正在成為市場的重要成長誘導因素。除此之外，日本政府在資金和有利的監管準則方面的一貫支持也為研發創造了更有利的環境。除此之外，人們對個人化醫療的認知不斷增強，加上對學術機構和私人企業之間研究合作的高度重視，正在市場上創造利潤豐厚的機會。此外，分子診斷平台在各種醫療保健環境中的廣泛可用性正在對市場產生積極影響。對醫療基礎設施的強勁投資以及公共衛生目標與技術創新的策略結合進一步推動了市場。除此之外，專注於預防保健和早期診斷的健康保險的滲透，以及專業實驗室和診所的激增，正在推動市場的發展。對該市場做出貢獻的其他一些因素包括日本受過高等教育的勞動力、先進的醫療保健系統以及強調醫療科學技術精確性和創新的文化。

日本分子診斷市場細分：

產品見解：

試劑和試劑盒
儀器儀表
軟體和服務

技術見解：

聚合酶鍊式反應 (PCR)
雜交
DNA定序
微陣列
等溫核酸擴增技術（INAAT）
其他

應用見解：

傳染病診斷
腫瘤學
基因檢測
血液篩檢
其他

最終使用者見解：

醫院
實驗室
其他

本報告回答的關鍵問題：

到目前為止，日本分子診斷市場的表現如何，未來幾年又會如何表現？
COVID-19 對日本分子診斷市場有何影響？
日本分子診斷市場依產品分類是怎樣的？
日本分子診斷市場在技術上的分化是什麼？
日本分子診斷市場在應用上的細分如何？
日本分子診斷市場的最終用戶細分如何？
日本分子診斷市場價值鏈的各個階段是什麼？
日本分子診斷市場的關鍵促進因素和挑戰是什麼？
日本分子診斷市場的結構如何？
日本分子診斷市場的競爭程度如何？

本報告回答的關鍵問題：

日本分子診斷市場迄今表現如何，未來幾年又將如何表現？
COVID-19 對日本分子診斷市場有何影響？
日本分子診斷市場依產品分類是怎樣的？
日本分子診斷市場在技術上的分化是什麼？
日本分子診斷市場在應用上的細分如何？
日本分子診斷市場的最終用戶細分如何？
日本分子診斷市場價值鏈的各個階段是什麼？
日本分子診斷市場的關鍵促進因素和挑戰是什麼？
日本分子診斷市場的結構如何？
日本分子診斷市場的競爭程度如何？

聚合酶鍊式反應 (PCR)
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
雜交
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
DNA定序
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
微陣列
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
等溫核酸擴增技術（INAAT）
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 8 章：日本分子診斷市場 - 細分：按應用分類

傳染病診斷
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
腫瘤學
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
基因檢測
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
血液篩檢
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 9 章：日本分子診斷市場 - 細分：按最終用戶分類

醫院
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
實驗室
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 10 章：日本分子診斷市場 - 競爭格局

概述
市場結構
市場參與者定位
最佳制勝策略
競爭儀表板
公司評估象限

第 11 章：關鍵參與者簡介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 12 章：日本分子診斷市場 - 產業分析

促進因素、限制因素和機會
- 概述
- 促進要素
- 限制
- 機會
波特五力分析
- 概述
- 買家的議價能力
- 供應商的議價能力
- 競爭程度
- 新進入者的威脅
- 替代品的威脅
價值鏈分析

第 13 章：附錄

簡介目錄

Product Code: SR112024A11068

The Japan molecular diagnostics market size reached USD 1.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.1 Billion by 2033, exhibiting a growth rate (CAGR) of 6% during 2025-2033. The increasing prevalence of chronic diseases, including cancer and cardiovascular ailments, the growing geriatric population requiring unique healthcare needs and a higher propensity for specific diseases, and the integration of advanced technologies such as next-generation sequencing and real-time PCR represent some of the key factors driving the market.

Molecular diagnostics refers to a collection of techniques used to analyze biological markers in the genome and proteome. This category of diagnostics enables medical professionals to detect and measure the presence of genetic material or proteins associated with a specific health condition or disease state. Molecular diagnostics are characterized by their precision, accuracy, and speed, as well as their essential role in the healthcare system. These diagnostic methods employ technologies such as PCR (polymerase chain reaction), ISH (in situ hybridization), and DNA sequencing to uncover specific genetic information. Their working mechanism involves extracting, amplifying, and analyzing genetic material, starting with the isolation of DNA or RNA to amplify targeted genetic regions. The amplified genetic material is then examined through various methods to identify mutations or changes, enabling healthcare providers to make informed decisions about diagnosis and treatment. The properties of molecular diagnostics such as sensitivity, specificity, and the ability to process multiple samples simultaneously make them advantageous in providing timely and tailored medical treatments, thereby offering a promising system to personalized medicine.

Japan Molecular Diagnostics Market Trends:

The market in Japan is primarily driven by the increasing prevalence of chronic diseases, including cancer and cardiovascular ailments, which necessitates the need for early and precise detection. In line with this, the growing geriatric population in Japan, requiring unique healthcare needs and a higher propensity for specific diseases, is also providing an impetus to the market. Moreover, the integration of advanced technologies such as next-generation sequencing and real-time PCR is acting as a significant growth-inducing factor for the market. In addition to this, the consistent support from the Japanese government in terms of funding and favorable regulatory guidelines is resulting in a more conducive environment for research and development. Besides this, the growing awareness about personalized medicine, coupled with a strong emphasis on research collaboration between academic institutions and private enterprises, is creating lucrative opportunities in the market. Also, the wide availability of molecular diagnostic platforms across various healthcare settings is impacting the market positively. The market is further driven by the robust investment in healthcare infrastructure and the strategic alignment of public health goals with technological innovation. Apart from this, the penetration of health insurance, focusing on preventive care and early diagnosis, along with the proliferation of specialized laboratories and clinics, is propelling the market. Some of the other factors contributing to the market include Japan's highly educated workforce, sophisticated healthcare system, and a cultural emphasis on precision and innovation in medical science and technology.

Japan Molecular Diagnostics Market Segmentation:

Product Insights:

Reagents and Kits
Instruments
Software and Services

Technology Insights:

Polymerase Chain Reactions (PCR)
Hybridization
DNA Sequencing
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others

Application Insights:

Infectious Diseases Diagnostics
Oncology
Genetic Testing
Blood Screening
Others

End User Insights:

Hospitals
Laboratories
Others

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan molecular diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan molecular diagnostics market?
What is the breakup of the Japan molecular diagnostics market on the basis of product?
What is the breakup of the Japan molecular diagnostics market on the basis of technology?
What is the breakup of the Japan molecular diagnostics market on the basis of application?
What is the breakup of the Japan molecular diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan molecular diagnostics market?
What are the key driving factors and challenges in the Japan molecular diagnostics market?
What is the structure of the Japan molecular diagnostics market and who are the key players?
What is the degree of competition in the Japan molecular diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Molecular Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Molecular Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Molecular Diagnostics Market - Breakup by Product

6.1 Reagents and Kits
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Software and Services
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)

7 Japan Molecular Diagnostics Market - Breakup by Technology

7.1 Polymerase Chain Reactions (PCR)
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Hybridization
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 DNA Sequencing
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Microarray
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2019-2024)
- 7.6.2 Market Forecast (2025-2033)

8 Japan Molecular Diagnostics Market - Breakup by Application

8.1 Infectious Diseases Diagnostics
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Genetic Testing
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Blood Screening
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Molecular Diagnostics Market - Breakup by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)

10 Japan Molecular Diagnostics Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Molecular Diagnostics Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis